[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 7 of about 7
1. Ishibashi K, Sobajima J, Okada N, Ishizuka N, Yokoyama M, Mitsuhashi T, Miyazaki T, Nakada H, Gonda T, Ishida H: [A case of pseudomyxoma peritonei successfully treated with multidisciplinary treatment including modified FOLFOX6 regimen]. Gan To Kagaku Ryoho; 2007 Nov;34(12):2047-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a case of pseudomyxoma peritonei caused by carcinoma of the appendix, which was successfully treated with multidisciplinary treatment including modified FOLFOX6 regimen.
  • A 45-year-old man was diagnosed as having peritoneal dissemination associated with cancer of the cecum or appendix.
  • At laparotomy, a diagnosis of pseudomyxoma peritonei caused by cancer of the appendix was made.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Pseudomyxoma Peritonei / drug therapy. Pseudomyxoma Peritonei / pathology
  • [MeSH-minor] Appendiceal Neoplasms / drug therapy. Appendiceal Neoplasms / pathology. Appendiceal Neoplasms / surgery. Colonoscopy. Fluorouracil / therapeutic use. Humans. Leucovorin / therapeutic use. Male. Middle Aged. Organoplatinum Compounds / therapeutic use. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Pseudomyxoma peritonei.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18219894.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; Folfox protocol
  •  go-up   go-down


2. Gehrig PA, Boggess JF, Ollila DW, Groben PA, Van Le L: Appendix cancer mimicking ovarian cancer. Int J Gynecol Cancer; 2002 Nov-Dec;12(6):768-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Appendix cancer mimicking ovarian cancer.
  • We describe five women who presented with signs and symptoms characteristic of advanced ovarian cancer but whose final diagnosis was stage IV appendiceal cancer.
  • Between 1998 and 1999, five women treated for presumed ovarian cancer were identified as having primary appendiceal cancer.
  • Four had postoperative chemotherapy, the most common agent used was 5-flourouracil.
  • Primary adenocarcinoma of the appendix is rare; therefore, the clinical utility of radical tumor debulking and chemotherapy is not well described.
  • Although this disease process is uncommon, it should be entertained by gynecologic oncologists in the differential diagnosis of an intra-abdominal mass and ascites.
  • The ability to make the correct diagnosis and differentiate between an ovarian and appendiceal primary is critical as the treatment modalities vary.
  • [MeSH-minor] Adult. CA-125 Antigen / blood. Chemotherapy, Adjuvant. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Keratins. Medical Records. Middle Aged. North Carolina / epidemiology. Palliative Care. Retrospective Studies. Survival Analysis. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12445258.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CA-125 Antigen; 68238-35-7 / Keratins
  •  go-up   go-down


3. Heimann DM, Schwartzentruber DJ: Gastrointestinal perforations associated with interleukin-2 administration. J Immunother; 2004 May-Jun;27(3):254-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • High-dose interleukin-2 (IL-2) results in objective clinical regression in up to 17% of patients with metastatic melanoma and renal cell carcinoma, with about half of these patients experiencing a complete regression of all lesions.
  • A retrospective review of all patients treated with IL-2 in the Surgery Branch of the National Cancer Institute (NCI) between Nov.
  • All six patients who underwent radiographic evaluation prior to diagnosis had free intraperitoneal air seen on the study.
  • The location of the perforation included the stomach, small bowel, appendix, and colon.
  • Two of the patients at the NCI had a ruptured appendix, which has not been previously reported in the literature.
  • The key to early diagnosis of GI perforation during IL-2 therapy is radiographic evaluation.
  • [MeSH-major] Digestive System / drug effects. Interleukin-2 / adverse effects. Interleukin-2 / therapeutic use. Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Carcinoma, Renal Cell / drug therapy. Female. Gastrointestinal Diseases / etiology. Humans. Male. Melanoma / drug therapy. Middle Aged

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15076143.001).
  • [ISSN] 1524-9557
  • [Journal-full-title] Journal of immunotherapy (Hagerstown, Md. : 1997)
  • [ISO-abbreviation] J. Immunother.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Interleukin-2
  • [Number-of-references] 20
  •  go-up   go-down


Advertisement
4. Mastoraki A, Papanikolaou IS, Kanakis D, Safioleas P, Sakorafas G, Safioleas M: A case of signet ring carcinoma of the appendix: dilemmas in differential diagnosis and management. J Gastrointest Cancer; 2010 Jun;41(2):141-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of signet ring carcinoma of the appendix: dilemmas in differential diagnosis and management.
  • PURPOSE: Signet ring carcinoma (SRC) of the appendix consists one of the most biologically virulent cancers.
  • We present the case of a patient with primary SRC complicated by the development of acute inflammation of the appendix.
  • Laparotomy confirmed a tumor mass which appeared to originate from the appendix.
  • The appendix was notably thickened with an ulcerated wall containing sinus tracts, chronic inflammation, and scarring.
  • CONCLUSIONS: Appendiceal SRC is a rare entity, which may sometimes be confused with other pathologies providing difficulties in differential diagnosis, having an impact on therapeutic decisions and affecting prognosis.
  • [MeSH-major] Appendiceal Neoplasms / pathology. Carcinoma, Signet Ring Cell / pathology
  • [MeSH-minor] Abdominal Pain. Aged. Antimetabolites, Antineoplastic / therapeutic use. Antineoplastic Agents / therapeutic use. Appendicitis / complications. Appendicitis / diagnosis. Appendicitis / surgery. Chemotherapy, Adjuvant. Diagnosis, Differential. Drug Therapy, Combination. Fluorouracil / therapeutic use. Humans. Laparotomy. Leucovorin / therapeutic use. Male. Organoplatinum Compounds / therapeutic use. Vitamin B Complex / therapeutic use. Vomiting

  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Colorectal Dis. 2007 Oct;22(10):1239-48 [17447078.001]
  • [Cites] Dis Colon Rectum. 2008 Jan;51(1):50-5 [18030531.001]
  • [Cites] Korean J Gastroenterol. 2004 Jan;43(1):29-34 [14745249.001]
  • [Cites] Kaohsiung J Med Sci. 2006 Dec;22(12 ):618-25 [17116623.001]
  • [Cites] G Chir. 2007 Mar;28(3):73-81 [17419903.001]
  • [Cites] Tidsskr Nor Laegeforen. 1999 Jan 30;119(3):371-2 [10074833.001]
  • [Cites] World J Gastroenterol. 2006 Mar 28;12(12):1975-7 [16610012.001]
  • [Cites] Histopathology. 2007 Apr;50(5):663-5 [17394504.001]
  • [Cites] Dis Colon Rectum. 2005 Dec;48(12):2264-71 [16258711.001]
  • [Cites] Minerva Chir. 2002 Oct;57(5):695-8 [12370673.001]
  • [Cites] Dis Colon Rectum. 1999 Dec;42(12):1618-25 [10613484.001]
  • [Cites] World J Surg Oncol. 2008 Jan 15;6:4 [18197972.001]
  • [Cites] Am J Clin Oncol. 1999 Oct;22(5):458-9 [10521058.001]
  • [Cites] World J Gastroenterol. 2008 Apr 7;14(13):2118-20 [18395918.001]
  • [Cites] Nihon Shokakibyo Gakkai Zasshi. 2000 May;97(5):580-4 [10846413.001]
  • (PMID = 20058100.001).
  • [ISSN] 1941-6636
  • [Journal-full-title] Journal of gastrointestinal cancer
  • [ISO-abbreviation] J Gastrointest Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents; 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; 12001-76-2 / Vitamin B Complex; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


5. Eveno C, Dagois S, Guillot E, Gornet JM, Pocard M: [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications]. Bull Cancer; 2008 Jan;95(1):141-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Traitement des carcinoses péritonéales par chirurgie et chimiothérapie hyperthermique intrapéritonéale peropératoire (Chip): des nouveautés mais aussi des indications validées.
  • Four indications are recognized by some tree national evaluation committees: the French ANAES, the British NICE and the Canadian CEPO: colorectal carcinoma, carcinoma of the appendix, pseudomyxoma peritonei and mesothelioma.
  • Last big published series results show a decrease of morbidity and mortality and interest of using new drugs like oxaliplatine.
  • [MeSH-major] Antineoplastic Agents / administration & dosage. Carcinoma / therapy. Chemotherapy, Cancer, Regional Perfusion / methods. Hyperthermia, Induced. Peritoneal Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18230580.001).
  • [ISSN] 1769-6917
  • [Journal-full-title] Bulletin du cancer
  • [ISO-abbreviation] Bull Cancer
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  • [Number-of-references] 26
  •  go-up   go-down


6. Rassu PC, Cassinelli G, Ronzitti F, Bronzino P, Stanizzi T, Casaccia M: [Primary adenocarcinoma of the appendix. Case report and review of the literature]. Minerva Chir; 2002 Oct;57(5):695-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary adenocarcinoma of the appendix. Case report and review of the literature].
  • [Transliterated title] Adenocarcinoma primitivo dell'appendice. Descrizione di un caso clinico e revisione della letteratura.
  • A rare case of primary adenocarcinoma of the vermiform appendix (less than 250 cases described in the literature) in a 36 year-old female patient presenting signs and symptoms of an acute appendicitis is reported.
  • Adeno-carcinoma of the vermiform appendix is a rare neoplasm of the gastrointestinal tract with an incidence of about 0,01-0,2%.
  • Usually the diagnosis of adenocarcinoma of the vermiform appendix is difficult because symptoms and signs are not pathognomonic.
  • In the case described, the diagnosis was intra and postoperative and confirmed by the pathological examination of the surgical specimens.
  • At laparotomy, performed under suspicion of an acute appendicitis, disseminated disease was discovered, characterized by the involvement of the two ovaries, the left colon, the cecum, the vermiform appendix, with a peritoneal carcinosis and a hydroureteronephrosis.
  • [MeSH-major] Adenocarcinoma / diagnosis. Appendiceal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Appendectomy. Appendicitis / diagnosis. Cecal Neoplasms / drug therapy. Cecal Neoplasms / secondary. Cecal Neoplasms / surgery. Chemotherapy, Adjuvant. Colonic Neoplasms / drug therapy. Colonic Neoplasms / secondary. Colonic Neoplasms / surgery. Diagnosis, Differential. Female. Fluorouracil / administration & dosage. Humans. Hydronephrosis / etiology. Laparotomy. Organoplatinum Compounds / administration & dosage. Ovarian Neoplasms / drug therapy. Ovarian Neoplasms / secondary. Ovarian Neoplasms / surgery. Peritoneal Neoplasms / drug therapy. Peritoneal Neoplasms / secondary. Peritoneal Neoplasms / surgery

  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12370673.001).
  • [ISSN] 0026-4733
  • [Journal-full-title] Minerva chirurgica
  • [ISO-abbreviation] Minerva Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; U3P01618RT / Fluorouracil
  • [Number-of-references] 13
  •  go-up   go-down


7. Andreopoulou E, Yee H, Warycha MA, Macari M, Berman R, Lowy A, Muggia F: Mucinous cancer of the appendix: challenges in diagnosis and treatment. J Chemother; 2007 Aug;19(4):451-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous cancer of the appendix: challenges in diagnosis and treatment.
  • The authors report and discuss a case of a mucinous carcinoma of the appendix, a rare entity with a distinct natural history that poses diagnostic and therapeutic challenges.
  • Mucinous peritoneal carcinomatosis is most commonly associated with primary tumors of the appendix and colon.
  • Treatment consists of surgical debulking, sometimes coupled with intraperitoneal drug delivery, but recurrence is universal.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / surgery. Appendiceal Neoplasms / diagnosis. Appendiceal Neoplasms / surgery. Appendix
  • [MeSH-minor] Aged. CA-19-9 Antigen / analysis. Carcinoembryonic Antigen / analysis. Fatal Outcome. Female. Humans

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17855191.001).
  • [ISSN] 1120-009X
  • [Journal-full-title] Journal of chemotherapy (Florence, Italy)
  • [ISO-abbreviation] J Chemother
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / T32CA09454
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / CA-19-9 Antigen; 0 / Carcinoembryonic Antigen
  •  go-up   go-down






Advertisement